Evidence map›Paper›PMID 26621207›Full record

ArticleWorld journal of urology2016

Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.

Giorgio Ivan Russo, Luca Vanella, Tommaso Castelli, Sebastiano Cimino, Giulio Reale, Daniele Urzì, Giovanni Li Volti, Mauro Gacci, Marco Carini, Fabio Motta and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Preliminary assessment of Neck Circumference in Benign Prostatic Hyperplasia in Patients with Metabolic Syndrome.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Giorgio Ivan RussoDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy. giorgioivan@virgilio.it.
Luca VanellaDepartment of Drug Science, Biochemistry Section, University of Catania, Catania, Italy.
Tommaso CastelliDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy.
Sebastiano CiminoDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy.
Giulio RealeDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy.
Daniele UrzìDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy.
Giovanni Li VoltiDepartment of Drug Science, Biochemistry Section, University of Catania, Catania, Italy.
Mauro GacciDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Marco CariniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Fabio MottaDepartment G.F. Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, Italy.
Rosario CaltabianoDepartment G.F. Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, Italy.
Lidia PuzzoDepartment G.F. Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, Italy.
Valeria SorrentiDepartment of Drug Science, Biochemistry Section, University of Catania, Catania, Italy.
Giuseppe MorgiaDepartment of Urology, School of Medicine, Policlinico Hospital, University of Catania, Catania, Italy.
University of Catania · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the relationship between intra-prostatic levels of heme oxygenase (HO), metaflammation in benign prostatic hyperplasia (BPH) tissue in patients with MetS and moderate-severe lower urinary tract symptoms (LUTS).

methodsBetween January 2012 and June 2013, 132 consecutive patients, who underwent transurethral resection of the prostate for moderate-severe LUTS, secondary to clinical BPH, were enrolled. Prostate samples were investigated for the presence of an inflammatory infiltrate, according to the Irani score, and for HO-1 and HO-2 levels measurements. Patients were evaluated for the presence of metabolic syndrome (MetS) defined by the International Diabetes Federation.

resultsWe observed that subjects with MetS exhibited greater Irani score (3.0 vs. 2.0; p < 0.05), Irani grade (2.0 vs. 1.0; p < 0.05) and lower value of HO-1 (4.55 vs. 6.01; p < 0.05) and HO-2 (0.81 vs. 2.66; p < 0.05). HO-1 (3.91 vs. 5.67; p < 0.05) and HO-2 (1.06 vs. 1.37; p < 0.05) were significantly reduced in patients with high intra-prostatic inflammation (Irani score ≥4). At the multivariate logistic regression analysis, HO-1 reduction (OR 0.588; p < 0.01), waist circumference (OR 1.09; p < 0.01), triglycerides (OR 1.013; p < 0.05) and HDL (OR 0.750; p < 0.05) were independent predictors of high intra-prostatic inflammation. We also found that HO-1 reduction (OR 0.598; p < 0.01) and the presence of MetS (OR 34.846; p < 0.01) were associated with Irani score ≥4.

conclusionMetS-induced inflammation may play a key role in BPH. In detail, prostate metaflammation is inversely related to intra-prostatic HO-1 levels, serum HDL and positively with triglycerides.

Indexed as

AgedHeme Oxygenase (Decyclizing)HumansLower Urinary Tract SymptomsMaleMetabolic SyndromeMiddle AgedProspective StudiesProstateProstatic HyperplasiaProstatitisSeverity of Illness IndexHeme Oxygenase (Decyclizing)Benign prostatic hyperplasiaFlogosisHDLHeme oxygenaseLUTSMetabolic syndromeProstateTriglycerides

Identifiers

PMID26621207
OpenAlexW2272515575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.